Document is current
Any future updates will be listed below
-
Authors
Sauer, Andrea
Stahl, Klaus
Seeliger, Benjamin
Wendel-Garcia, Pedro David
Lehmann, Felix
Schmidt, Julius J.
Schmidt, Bernhard M. W.
Welte, Tobias
Peukert, Konrad
Wild, Lennart
Putensen, Christian
David, Sascha https://orcid.org/0000-0002-8231-0461
Bode, Christian
,
Kleinert, Eva-Maria
Erlebach, Rolf
Andermatt, Rea
Hofmaenner, Daniel Andrea
Mueller, Mattia
Schuepbach, Reto
Buhlmann, Alix
Pape, Thorben
Rath, Ann-Kathrin
Nalbant, Bahar
Ruwisch, Jannik
Feuerborn, Caroline
Kruse, Philippe
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DA1209/7-3)
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 29 January 2025
First Online: 14 February 2025
Declarations
:
: The trial was conducted according to the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of the Hannover Medical School (No. 2786–2015 and No. 8852_MPG_23b_2020) and the University Hospital Bonn (No. 024/20). Written informed consent was provided by participants or their legal representatives prior to enrollment. The study was registered at clincaltrials.gov (Identifier: NCT04231994).
: Not applicable.
: Sascha David is supported by an unrestricted research Grant from Cytosorbents for an RCT to test CytoSorb in CRS (CYTORELEASE-Ex). The other authors declare that they have no competing interests.
